252 related articles for article (PubMed ID: 2809398)
1. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
[TBL] [Abstract][Full Text] [Related]
2. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
3. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR; Bacon S
Metabolism; 1989 Jun; 38(6):542-9. PubMed ID: 2725293
[TBL] [Abstract][Full Text] [Related]
4. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
5. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
6. [Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy].
Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; García Alegría JJ; Gascón Luna F; Masana Marín L
An Esp Pediatr; 1990 Jul; 33(1):58-60. PubMed ID: 2252289
[TBL] [Abstract][Full Text] [Related]
7. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
8. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.
Prihoda JS; Pappu AS; Smith FE; Illingworth DR
J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
10. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
[TBL] [Abstract][Full Text] [Related]
11. Treatment of familial hypercholesterolemia with drugs in children.
Stein EA
Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
13. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
14. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
Atherosclerosis; 2002 Nov; 165(1):137-44. PubMed ID: 12208479
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB
Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127
[TBL] [Abstract][Full Text] [Related]
17. Combined drug therapy for familial hypercholesterolemia.
Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
Artery; 1980; 7(4):281-9. PubMed ID: 7213018
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
20. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
Stugaard M; Wiig I; Lund H; Ose L; Norseth J
Tidsskr Nor Laegeforen; 1992 Aug; 112(20):2642-6. PubMed ID: 1412289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
